Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
Study NCT ID:
NCT00186095
Status:
WITHDRAWN
Last Update Posted:
2022-06-23
First Post:
2005-09-13
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Mixed Chimeric Transplantation for Primary Amyloidosis
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'removedCountries': ['United States']}, 'conditionBrowseModule': {'meshes': [{'id': 'D000686', 'term': 'Amyloidosis'}], 'ancestors': [{'id': 'D057165', 'term': 'Proteostasis Deficiencies'}, {'id': 'D008659', 'term': 'Metabolic Diseases'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 0}}, 'statusModule': {'whyStopped': 'Closed, never started.', 'overallStatus': 'WITHDRAWN', 'startDateStruct': {'date': '2000-12'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-06', 'completionDateStruct': {'date': '2006-09'}, 'lastUpdateSubmitDate': '2022-06-16', 'studyFirstSubmitDate': '2005-09-13', 'studyFirstSubmitQcDate': '2005-09-13', 'lastUpdatePostDateStruct': {'date': '2022-06-23', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2005-09-16', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Treatment of patients with nonmyeloablative allogeneic transplant for amyloidosis.'}], 'secondaryOutcomes': [{'measure': 'Toxicity of therapy'}, {'measure': 'Changes in marrow and serum abnormalities'}, {'measure': 'Improvement in end-organ function.'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Amyloidosis', 'nonmyeloablative', 'hematopoietic', 'cell transplantation'], 'conditions': ['Amyloidosis']}, 'descriptionModule': {'briefSummary': 'To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT'], 'maximumAge': '60 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* primary amyloidosis\n* adequate organ function\n* matched sibling donor\n\nExclusion Criteria:\n\n* evidence of multiple myeloma\n* HIV positive'}, 'identificationModule': {'nctId': 'NCT00186095', 'briefTitle': 'Mixed Chimeric Transplantation for Primary Amyloidosis', 'organization': {'class': 'OTHER', 'fullName': 'Stanford University'}, 'officialTitle': 'Mixed Chimeric Transplantation for Primary Amyloidosis', 'orgStudyIdInfo': {'id': 'BMT129'}}, 'armsInterventionsModule': {'interventions': [{'name': 'autologous followed by nonmyeloablative allogeneic transplant', 'type': 'PROCEDURE'}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Keith Stockerl-Goldstein, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Stanford University'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Stanford University', 'class': 'OTHER'}}}}